Saturday, August 17, 2024 11:25:24 AM
Wrong again HyGro
Your comments are biased and once again prove that DCVax is moving forward, IMPO.
Furthermore, your comment below has zero weighting factor with respect to article bashing vs. the number of support articles for DCVax. "7 journal articles point out the clear bias of redoing the protocol TWO WEEKS before the end of the trial."
Articles that were paid by sources that focus on trashing NWBO while 100's of articles have been written supporting the effectiveness of NWBO's DCVax, IMPO. I would rather trust Dr. Linda Liau and her team at UCLA plus the NWBO team including the 100's of doctors, oncologists, cancer clinics, and universities that support DCVax. BTW, the FDA is fully aware of DCVax with respect to the advanced research and progress both at UCLA and NWBO, IMPO.
Your comments are biased and once again prove that DCVax is moving forward, IMPO.
Furthermore, your comment below has zero weighting factor with respect to article bashing vs. the number of support articles for DCVax. "7 journal articles point out the clear bias of redoing the protocol TWO WEEKS before the end of the trial."
Articles that were paid by sources that focus on trashing NWBO while 100's of articles have been written supporting the effectiveness of NWBO's DCVax, IMPO. I would rather trust Dr. Linda Liau and her team at UCLA plus the NWBO team including the 100's of doctors, oncologists, cancer clinics, and universities that support DCVax. BTW, the FDA is fully aware of DCVax with respect to the advanced research and progress both at UCLA and NWBO, IMPO.
Bullish
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
